Gastro Florida
Clearwater, Florida, United States
Gastroenterologist in Feather Sound, Florida
3001 Executive Dr #130, Clearwater, FL 33762
About Gastro Florida
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gastro Florida
During the past decade, Gastro Florida conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 17 clinical trials were completed, i.e. on
average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 17 clinical trials were completed. i.e. 130.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
2018-04-24
2020-01-16
Completed
530
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
2018-09-03
2022-02-07
Terminated
1,936
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
2019-06-27
2020-11-26
Completed
179
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
2022-03-08
2024-05-28
Recruiting
170
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
2023-01-25
2026-10-02
Recruiting
33
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gastro Florida" #1 sponsor was "Celgene" with 7 trials, followed by "Pfizer" with 5 trials
sponsored, "Shire" with 5 trials sponsored, "Target PharmaSolutions, Inc." with 5 trials sponsored and "Hoffmann-La Roche"
with 5 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gastro Florida"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Gastro Florida
According to Clinical.Site data, the most researched conditions in "Gastro Florida" are
"Ulcerative Colitis" (14 trials), "Crohn's Disease" (10 trials), "Crohn Disease" (8 trials), "Colitis, Ulcerative" (4 trials) and "Clostridium Difficile Infection Recurrence" (2 trials). Many other conditions were trialed in "Gastro Florida" in a lesser frequency.
Clinical Trials Intervention Types at Gastro Florida
Most popular intervention types in "Gastro Florida" are "Drug" (39 trials), "Other" (10 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "Etrasimod" (5 trials), "Etrolizumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Gastro Florida
The vast majority of trials in "Gastro Florida" are
47 trials for "All" genders.
Clinical Trials Status at Gastro Florida
Currently, there are NaN active trials in "Gastro Florida".
undefined are not yet recruiting,
17 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Gastro Florida,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Gastro Florida, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".